BioMarin Pharmaceutical Financial Overview
BioMarin Pharmaceutical's market cap is currently $11.52B. The company's EPS TTM is $-0.16; its P/E ratio is 22.46; BioMarin Pharmaceutical is scheduled to report earnings on October 27, 2025, and the estimated EPS forecast is $0.81. See an overview of income statement, balance sheet, and cash flow financials.
